Universal Health Services
UHS
174.62
-2.46
-1.39%
Universal Health Services
US · UHS
#1440 by market cap
Listed 1970
174.62
-2.46
-1.39%
Live - 5344 symbols - heartbeat 360s ago
· 2026-10-08 06:08
Pre-market
174.00
-0.36%
After-hours
174.62
0.00%
- Market cap
- 10.29B
- P/E (TTM)i
- 7.13
- P/Bi
- 1.37
- EPSi
- 23.10
- Div yieldi
- 0.46%
- 52W posi
- 33%
Reader sentiment
Are you bullish or bearish on UHS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 90.41% +0.05pp
- Institutions
- 733 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund75.14%
Individual/Insider14.69%
Hedge Fund6.16%
Public Company2.46%
Government Pension Fund2.20%
Private Company1.95%
Sovereign Wealth Fund1.55%
Family Office/Trust0.31%
Insurance Company0.22%
Top holders
Alan Miller
13.53%
First Eagle Investment Management, LLC
7.73%
BlackRock
6.89%
Vanguard Capital Management, LLC
6.26%
Vanguard Portfolio Management, LLC
4.16%
Dimensional Fund Advisors
3.75%
State Street Global Advisors
3.57%
Geode Capital Management, LLC
3.35%
Pzena Investment Management, Inc.
3.34%
Invesco Capital Management LLC
2.94%
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 27 buys · 23 sells
| Name | Role | Stake |
|---|---|---|
| Alan Miller | Executive Chairperson | 13.53% |
| Marc Miller | Chief Executive Officer | 0.55% |
| Steve Filton | Chief Financial Officer | 0.49% |
| Matthew Peterson | Executive VP & President of Behavioral Health Division | 0.03% |
| Edward Sim | Executive VP & President of Acute Care Division | 0.02% |
| Maria Singer | Independent Director | 0.01% |
| Warren Nimetz | Director | 0.01% |
| Eileen McDonnell | Lead Independent Director | 0.01% |
| Elliot Sussman | Independent Director | 0.01% |
| Nina Chen-Langenmayr | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-05-26 | Alan Miller | Executive Chairperson | Other Acquisition | +177,268 | -- |
| 2026-05-26 | Alan Miller | Executive Chairperson | Other Disposition | -177,268 | -- |
| 2026-05-19 | Elliot Sussman | Independent Director | Other Acquisition | +1,217 | -- |
| 2026-05-19 | Warren Nimetz | Director | Other Acquisition | +1,217 | -- |
| 2026-05-19 | Eileen McDonnell | Lead Independent Director | Other Acquisition | +1,217 | -- |
| 2026-05-19 | Maria Singer | Independent Director | Other Acquisition | +1,217 | -- |
| 2026-05-19 | Nina Chen-Langenmayr | Independent Director | Other Acquisition | +1,217 | -- |
| 2026-03-25 | Alan Miller | Executive Chairperson | Other Acquisition | +14,153 | -- |
| 2026-03-25 | Steve Filton | Chief Financial Officer | Other Acquisition | +6,850 | -- |
| 2026-03-25 | Marc Miller | Chief Executive Officer | Other Acquisition | +29,715 | -- |
| 2026-03-25 | Edward Sim | Executive VP & President of Acute Care Division | Other Acquisition | +6,404 | -- |
| 2026-03-25 | Matthew Peterson | Executive VP & President of Behavioral Health Division | Other Acquisition | +5,627 | -- |
| 2026-03-20 | Alan Miller | Executive Chairperson | Sale to Issuer | -2,576 | $185.82–189.58 |
| 2026-03-20 | Steve Filton | Chief Financial Officer | Sale to Issuer | -1,347 | $185.82–189.58 |
| 2026-03-20 | Marc Miller | Chief Executive Officer | Sale to Issuer | -5,001 | $185.82–189.58 |
| 2026-03-20 | Edward Sim | Executive VP & President of Acute Care Division | Sale to Issuer | -1,297 | $185.82–189.58 |
| 2026-03-20 | Matthew Peterson | Executive VP & President of Behavioral Health Division | Sale to Issuer | -1,120 | $185.82–189.58 |
| 2026-03-12 | Elliot Sussman | Independent Director | Derivative Exercise and Sale | -2,500 | $138.80–194.27 |
| 2026-03-11 | Alan Miller | Executive Chairperson | Sale to Issuer | -13,045 | $190.49 |
| 2026-03-11 | Alan Miller | Executive Chairperson | Other Acquisition | +33,149 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 06:08:41 · For reference only, not investment advice and not tailored to your situation.